CLEAR Outcomes trial

Study / Research

The major cardiovascular outcome trial for Bempedoic Acid, which enrolled nearly 50% women (likely due to higher statin intolerance) and is anticipated to show significant benefits.

Mentioned in 1 video

Videos Mentioning CLEAR Outcomes trial

230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more

230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more

Peter Attia MD

The major cardiovascular outcome trial for Bempedoic Acid, which enrolled nearly 50% women (likely due to higher statin intolerance) and is anticipated to show significant benefits.